These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20040699)

  • 1. INR elevation with maitake extract in combination with warfarin.
    Hanselin MR; Vande Griend JP; Linnebur SA
    Ann Pharmacother; 2010 Jan; 44(1):223-4. PubMed ID: 20040699
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
    Evans M; Lewis GM
    Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected suppression of the INR by thiazolidinediones: interaction between warfarin and TZDs.
    Hoffmann TK; Parker DL; Buch HA; Balusu P
    Ann Pharmacother; 2006 May; 40(5):994-6. PubMed ID: 16670367
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
    Schwartz JI; Liu F; Stroh M; Gipson A; Johnson-Levonas AO; Lasseter KC; Lai E; Wagner JA
    Am J Ther; 2009; 16(3):215-23. PubMed ID: 19454860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in anticoagulant effect of warfarin in a patient using econazole cream.
    Lang PG; LeClercq AH
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S117-9. PubMed ID: 17052529
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral anticoagulants and cyclosporin A.
    Turri D; Iannitto E; Caracciolo C; Mariani G
    Haematologica; 2000 Aug; 85(8):893-4. PubMed ID: 10942954
    [No Abstract]   [Full Text] [Related]  

  • 9. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible warfarin failure due to interaction with smokeless tobacco.
    Kuykendall JR; Houle MD; Rhodes RS
    Ann Pharmacother; 2004 Apr; 38(4):595-7. PubMed ID: 14766993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential interaction between warfarin and high dietary protein intake.
    Hornsby LB; Hester EK; Donaldson AR
    Pharmacotherapy; 2008 Apr; 28(4):536-9. PubMed ID: 18363537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
    Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
    Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan potentiation of warfarin effect.
    Huang SS; Sung SH; Chiang CE
    Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.
    Dericioglu N; Babaoglu MO; Saygi S; Bozkurt A; Yasar U
    Ann Pharmacother; 2004 May; 38(5):899. PubMed ID: 15039471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.